Work

In-silico Design and Biological Activity Prediction of Novel Benzoxazole–chalcone Hybrids

Year: 2026
Type: article
Abstract: ABSTRACTChalcone and benzoxazole are significant medicinal-chemistry scaffolds linked to a variety ofdocumented biological actions. The purpose of this work was to create new benzoxazole–chalconehybrid compounds and evaluate their anticipated activity using computational techniques. Forantitubercular, antioxidant, anti-inflammatory, anticancer, and antidiabetic research, Five derivatives(BOC1–BOC5) were created and categorized. ACD/Labs ChemSketch 2024 was used to create SMILESand chemical structures. SwissADME was used to evaluate pharmacokinetic characteristics, PreADMETwas used to predict toxicity, and Molinspiration was used to evaluate drug-likeness. AutoDock Vina1.1.2 was used for molecular docking against DprE1 (4P8N), ascorbate peroxidase (10AF), COX-2(1PXX), TOP2A (5GWK), and α-glucosidase (3W37); PyMOL and BIOVIA Discovery were used todisplay poses and interactions.There were no documented Lipinski Rule of Five breaches in any of the 5 variants. P-glycoproteinsubstrate predictions, PAINS alarms, and high gastrointestinal absorption for all drugs were all predictedby SwissADME. In the antioxidant target, BOC6 scored -10.1 kcal/molBOC3scored -8.8 kcal/molagainst COX-2 BOC4 scored -7.6 kcal/mol against TOP2A; and BOC5 scored -9.6 kcal/mol against α-glucosidase. BOC1 had the best antitubercular docking score of -10.4 kcal/mol. These computationalfindings do not prove biological efficacy, but they do highlight potential subjects for additional research.Safety assessment, synthesis, and experimental biological testing are necessary.
Source: Degrés
Language: English
Subfield: Drug Discovery
Open Access status: hybrid
OpenAlex ID: W7236063160
FWCI:
Cites:
Cited by:
Related to: 10